The clinical signs of strongyloidiasis vary depending on the severity of infection and the age and immune status of the animal (1, 3) .
Diagnosis of S. stercoralis infection is difficult due to its complex life cycle and the irregularly excreted larvae may be small in number or absent from the feces, even in cases of clinical disease (3) . There are many diagnostic methods used to detect S. stercoralis including direct smear examination, the Baermann method, coproculture, intestinal biopsy, or aspirate and also some serological and molecular techniques such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) (1, 5, (7) (8) (9) . However, each technique has some problems with sensitivity, specificity, cost, or applicability, so there is no gold standard for diagnosing S. stercoralis (8) .
Direct smear, fecal flotation with zinc sulfate, and the Baermann method are cheap, simple, and easily applicable methods in all parasitology laboratories. However, they have low sensitivity and a single examination can fail to detect larvae in all cases, so they need repeated tests or collections of samples on different days (10).
There are many drugs of choice for the treatment of adult S. stercoralis in dogs. For this purpose, ivermectin (0.2 mg/kg, subcutaneously or per os (PO), with a second dose 4 weeks later; once, 0.8 mg/kg, PO), fenbendazole (once a day for 3-5 days at 50 mg/kg, repeated 4 weeks later), albendazole (twice daily for 3 consecutive days at 100 mg/kg) (11, 12) , and selamectin (once a day at 6 mg/ kg) are used.
S. stercoralis has a cosmopolitan distribution in tropical and subtropical regions but may also be found in temperate zones in humans in the world, whereas it is sporadic in humans and rarely seen in dogs in Turkey (13) .
In Turkey, there is only one old study available about the presence and prevalence of Strongyloides sp. in dogs and cats in which the prevalence of the parasite was recorded as 0.54% and 0.58%, respectively. There is no clinical case report in dogs and cats in Turkey (14, 15) .
The present study describe a clinical strongyloidiasis case for the first time in Turkey and successful treatment of S. stercoralis infection in a dog with ivermectin administered subcutaneously.
Case history
A 2.5-year-old small male Cavalier King Charles spaniel weighting 3.8 kg was presented to Ondokuz Mayıs University's Faculty of Veterinary Medicine Animal Hospital with symptoms including severe watery diarrhea, pain at defecation, intermittent cough, vomiting, and emaciation.
Fresh fecal samples were collected from the infected dog on days 1, 3, 7, and 14 for parasitological examination by direct fecal smears and the Baermann method (2,10). Larvae count was performed per gram of feces with the Baermann method and then 10 larvae were examined. Characteristics used in morphological identification of the parasite were measured and larvae were photographed.
The larvae and young female nematodes were examined with a microscope (Nikon Eclipse 80i, Tokyo, Japan) connected to a digital camera and specific software used for measurements (Nikon DS-L1), and they were identified using morphological keys (1,3,5,10).
After confirmation, the dog was treated with ivermectin (0.2 mg/kg subcutaneously) and multivitamin syrup (Vitabiol) for 5 days.
Results and discussion
Examination of the fecal smear revealed a moderate amount of S. stercoralis larvae and two adult females. Larval count was performed in feces with the Baermann method and 20 larvae were determined per gram of feces.
There is no gold-standard method for diagnosis of S. stercoralis (1, (7) (8) (9) . In our study direct fecal smears and the Baermann method were preferred because they are cheap, easy, and less time-consuming. However, these methods require a considerably larger quantity of stools, which might lead to compliance problems if an additional sample is required due to insufficient volume.
The first-stage larvae were easily identified as the genital primordium was clearly seen, which is the factor that allows S. stercoralis to be easily differentiated from other nematode larvae in dogs or free-living nematodes (3, 5) .
In this study, the first-stage (L 1 ) larvae (n: 10) typically had a rhabditiform esophagus. Figure 1A) .
The young females (n: 2) were 1.320 (1.215-1.425) mm long and 34-36 μm wide with a very long cylindrical esophagus that occupied nearly the anterior half of the body ( Figure 1B) . The vulva was located posteriorly. The tail was short, narrow, and sharply tapered ( Figure 1C) .
The morphological characters of the female parasites were also compatible with the findings of published studies (1,2,5,10).
Infections in dogs can be treated with ivermectin, fenbendazole, albendazole, and thiabendazole (12, 13) . In our study the dog was treated with ivermectin (Avromec, 0.2 mg/kg subcutaneously) and multivitamin syrup (Vitabiol) for 5 days.
There were no larvae in fecal examinations of the samples that were taken after the third day of ivermectin treatment. This result showed that ivermectin was effective against all larval stages and adults in the small intestines.
Yang et al. (12) reported that ivermectin was 100% effective against L 1 , L 2 , and adults of S. stercoralis in dogs but it was not effective against tissue-dwelling L 3 . Fenbendazole and others were used for treatment, as well (11) .
There is no efficient drug against autoinfective migratory larvae so treatment of actively hyperinfected dogs may be difficult (3) . Fecal examination in all treated animals should be done weekly for 2 to 3 weeks to detect larvae. Ideally, prevention, by improved sanitation (suitable disposal of feces), practicing of good hygiene (wearing gloves and washing hands), etc., is used before any drug regimen is administered.
It has been suggested that cases of diarrhea should be considered for S. stercoralis, especially for young puppies, and at least the direct stool smears method should be applied for the larvae. The result of the present case suggests that ivermectin is suitable for treatment of dogs naturally infected with S. stercoralis. However, this treatment regimen is not approved for all animals and feces should be examined regularly for at least 6 months after treatment to confirm efficacy.
Some helminths such as S. stercoralis can also be transmitted to humans, including animal owners, as well as to veterinary practitioners and veterinary nurses. Therefore, the possibility of S. stercoralis transmission to humans cannot be eliminated.
In conclusion, there is no reported study about the prevalence and/or pathogenicity of S. stercoralis in dogs in Turkey. The present case shows that S. stercoralis can cause disease in mature dogs and infection may become a chronic problem in appropriate environments. Infection could be diagnosed by direct smears and/or the Baermann technique, but they are not routinely performed in small animal practice in Turkey. A single subcutaneous dose of ivermectin (0.05 mL, 1% w/v) was found to be effective in the current case with subsiding of symptoms and larval disappearance upon fecal examination. 
